- Home
- MKTW vs SER Comparison
MKTW vs SER Comparison
Compare MKTW & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKTW
- SER
- Stock Information
- Founded
- MKTW 1999
- SER 2017
- Country
- MKTW United States
- SER United States
- Employees
- MKTW N/A
- SER N/A
- Industry
- MKTW Computer Software: Prepackaged Software
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- MKTW Technology
- SER Health Care
- Exchange
- MKTW Nasdaq
- SER Nasdaq
- Market Cap
- MKTW 48.2M
- SER 56.5M
- IPO Year
- MKTW N/A
- SER 2018
- Fundamental
- Price
- MKTW $17.65
- SER $5.04
- Analyst Decision
- MKTW Hold
- SER Strong Buy
- Analyst Count
- MKTW 1
- SER 2
- Target Price
- MKTW $20.00
- SER $13.00
- AVG Volume (30 Days)
- MKTW 13.9K
- SER 328.9K
- Earning Date
- MKTW 11-06-2025
- SER 08-11-2025
- Dividend Yield
- MKTW 4.48%
- SER N/A
- EPS Growth
- MKTW 59.71
- SER N/A
- EPS
- MKTW 2.83
- SER N/A
- Revenue
- MKTW $358,121,000.00
- SER $130,000.00
- Revenue This Year
- MKTW N/A
- SER N/A
- Revenue Next Year
- MKTW N/A
- SER N/A
- P/E Ratio
- MKTW $6.30
- SER N/A
- Revenue Growth
- MKTW N/A
- SER N/A
- 52 Week Low
- MKTW $9.08
- SER $3.81
- 52 Week High
- MKTW $21.74
- SER $10.28
- Technical
- Relative Strength Index (RSI)
- MKTW 43.71
- SER 43.16
- Support Level
- MKTW $17.70
- SER $4.90
- Resistance Level
- MKTW $18.08
- SER $5.34
- Average True Range (ATR)
- MKTW 0.40
- SER 0.53
- MACD
- MKTW -0.03
- SER -0.02
- Stochastic Oscillator
- MKTW 22.73
- SER 10.33
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.